These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17428155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R, Khachikian D, Reboli AC.
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of caspofungin in HIV-infected individuals.
    Waters L, Nelson M.
    Expert Opin Investig Drugs; 2007 Jun; 16(6):899-908. PubMed ID: 17501701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G, Glasmacher A.
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [Abstract] [Full Text] [Related]

  • 12. Micafungin: a new echinocandin.
    Chandrasekar PH, Sobel JD.
    Clin Infect Dis; 2006 Apr 15; 42(8):1171-8. PubMed ID: 16575738
    [Abstract] [Full Text] [Related]

  • 13. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB, Rathi SA, Ratho N, Subramanian R.
    J Assoc Physicians India; 2006 Dec 15; 54():943-8. PubMed ID: 17334012
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice.
    Abruzzo GK, Gill CJ, Flattery AM, Kong L, Leighton C, Smith JG, Pikounis VB, Bartizal K, Rosen H.
    Antimicrob Agents Chemother; 2000 Sep 15; 44(9):2310-8. PubMed ID: 10952573
    [Abstract] [Full Text] [Related]

  • 15. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G, Figgitt D.
    Drugs; 2003 Sep 15; 63(20):2235-63. PubMed ID: 14498760
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The first echinocandin: caspofungin.
    Cornely OA, Schmitz K, Aisenbrey S.
    Mycoses; 2002 Sep 15; 45 Suppl 3():56-60. PubMed ID: 12690973
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
    Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N.
    Cancer; 2006 Jan 15; 106(2):466-73. PubMed ID: 16353208
    [Abstract] [Full Text] [Related]

  • 19. The echinocandins: three useful choices or three too many?
    Bal AM.
    Int J Antimicrob Agents; 2010 Jan 15; 35(1):13-8. PubMed ID: 19942413
    [Abstract] [Full Text] [Related]

  • 20. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
    Wiederhold NP, Lewis JS.
    Expert Opin Pharmacother; 2007 Jun 15; 8(8):1155-66. PubMed ID: 17516879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.